Weight Loss
Semaglutide
5mg / vial
A long-acting GLP-1 receptor agonist studied extensively in preclinical research for glucose control through pancreatic beta-cell activation and insulin secretion, appetite and weight reduction via CNS pathways, and cardiometabolic effects including blood pressure and lipid profile modulation.
$119.99
Size
≥98% Purity
Third-party verified
Cold-Chain Shipping
Free on every order
COA Included
HPLC · LC-MS · NMR
Same-Day Shipping
Orders before 1PM EST
For Research Use Only. Not for human or animal consumption. Not a drug, food, or cosmetic. For in vitro laboratory research by qualified researchers only.
Areas of Investigation
Research Applications
Blood Sugar
Glucose Regulation
Extensively studied for its ability to stimulate glucose-dependent insulin secretion and suppress glucagon release through GLP-1 receptor activation.
Weight Loss
Body Weight & Appetite
Demonstrated significant weight reduction in large-scale clinical trials through appetite suppression and delayed gastric emptying.
Heart Health
Cardiovascular Research
Evaluated in clinical trials for reduction of major adverse cardiovascular events in patients with type 2 diabetes.
Metabolism
Metabolic Syndrome
Studied for broad metabolic effects including improvements in blood pressure, lipid profiles, and inflammatory markers.
Technical Data
Compound Profile
Full compound characterization including molecular structure, physical properties, storage requirements, and stability data for research use.
≥98% Purity Guaranteed
HPLC · LC-MS · Third-Party Verified
Molecular Formula
C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight
4,113.58 g/mol
Appearance
White to off-white lyophilized powder
Storage (Lyophilized)
Below −20°C, desiccated, away from light and moisture
Storage (Reconstituted)
Refrigerate at 2–8°C; use within 28 days. Protect from light.
Shelf Life
24 months from manufacture date
Third-Party Verified
Certificate of Analysis
99.65%
PURITY
Semaglutide · Batch A
TAP TO VIEW FULL COA
Batch Analysis Report
Lot Number
PLQ-SEMA-2601-A
Labeled Amount
5mg
Actual Amount
5.38mg
Testing Date
01/20/2026
Tested By
Apex Analytics Lab (Third-Party)
Methods
HPLC · LC-MS · NMR · FTIR
Full COA documentation is included with every order. COAs are batch-specific and reflect the exact lot shipped. Independent third-party verification ensures unbiased purity and identity confirmation.
Protocol
Storage & Handling
Long-Term Storage
Store lyophilized peptide at −20°C. Under these conditions the product remains stable for up to 24 months from the date of manufacture.
After Reconstitution
Once reconstituted, store at 4°C and use within 30 days. Avoid repeated freeze-thaw cycles as this may degrade compound integrity.
Shipping Conditions
All orders ship in insulated packaging with cooling packs to maintain the cold chain during transit. Free on every order, no minimum required.
Support
Frequently Asked Questions
Semaglutide features a C-18 fatty acid side chain that enables strong albumin binding, extending its half-life to approximately 7 days. It shares 94% structural similarity with native human GLP-1 and is among the most extensively studied GLP-1 receptor agonists in preclinical and clinical research.
Semaglutide is a selective GLP-1 receptor agonist. Tirzepatide adds dual GIP/GLP-1 activity. Retatrutide is a triple agonist (GLP-1, GIP, glucagon). Each compound offers a progressively broader receptor profile for comparative metabolic research.
This is research-grade semaglutide — the same molecule studied in clinical trials but not equivalent to FDA-approved pharmaceutical formulations. It is strictly for in vitro laboratory research by qualified researchers. Not for human or animal consumption.
Add bacteriostatic water slowly along the vial wall and gently swirl until fully dissolved. Do not shake. Semaglutide is sensitive to agitation — store reconstituted solution at 2–8°C, protected from light, and use within 28 days.
Our semaglutide is verified at ≥98% purity via third-party HPLC analysis. The current batch is confirmed at 99.65% by Apex Analytics Lab. A full COA ships with every order.
Explore More
Related Products
Weight Loss
Tirzepatide
A synthetic dual GIP/GLP-1 receptor agonist investigated for effects on glucose metabolism, insulin secretion, and appetite regulation. Research examines HbA1c reduction, substantial weight loss outcomes, liver fat content changes, and cardiometabolic parameters including blood pressure and lipid profiles in obesity and type 2 diabetes models.
$129.99
Weight Loss
Retatrutide
A synthetic triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways. Researched for body-weight reduction, glucose regulation, and energy expenditure in obesity models. Combined GLP-1/GIP signaling is examined for glycemic control, while glucagon receptor activation is studied for hepatic glucose output and lipid metabolism effects.
$99.99